Your browser is no longer supported. Please, upgrade your browser.
VKTX Viking Therapeutics, Inc. daily Stock Chart
VKTX [NASD]
Viking Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.36 Insider Own2.50% Shs Outstand74.05M Perf Week-2.87%
Market Cap325.82M Forward P/E- EPS next Y-0.81 Insider Trans0.00% Shs Float64.59M Perf Month-27.15%
Income-25.80M PEG- EPS next Q-0.12 Inst Own56.90% Short Float22.83% Perf Quarter-43.37%
Sales- P/S- EPS this Y6.50% Inst Trans0.17% Short Ratio10.92 Perf Half Y-36.87%
Book/sh3.84 P/B1.15 EPS next Y-37.30% ROA-8.80% Target Price22.10 Perf Year-57.36%
Cash/sh3.72 P/C1.18 EPS next 5Y40.00% ROE-9.00% 52W Range3.26 - 11.03 Perf YTD-45.14%
Dividend- P/FCF- EPS past 5Y32.40% ROI- 52W High-60.11% Beta2.09
Dividend %- Quick Ratio41.80 Sales past 5Y- Gross Margin- 52W Low34.97% ATR0.47
Employees16 Current Ratio41.80 Sales Q/Q- Oper. Margin- RSI (14)42.42 Volatility7.23% 11.54%
OptionableYes Debt/Eq0.00 EPS Q/Q-40.90% Profit Margin- Rel Volume0.67 Prev Close4.49
ShortableYes LT Debt/Eq0.00 EarningsFeb 26 AMC Payout- Avg Volume1.35M Price4.40
Recom1.50 SMA20-2.31% SMA50-22.86% SMA200-36.99% Volume898,878 Change-2.00%
Jul-16-19Initiated Oppenheimer Outperform $12
Jun-25-19Initiated Stifel Buy
Mar-29-19Upgrade SVB Leerink Mkt Perform → Outperform $10 → $21
Mar-14-19Reiterated Maxim Group Buy $28 → $20
Feb-22-19Initiated SVB Leerink Mkt Perform
Dec-12-18Initiated B. Riley FBR Buy $16
Nov-19-18Upgrade Raymond James Outperform → Strong Buy
Sep-18-18Reiterated Raymond James Outperform $15 → $43
Sep-18-18Reiterated Maxim Group Buy $14 → $28
Sep-18-18Reiterated H.C. Wainwright Buy $15 → $28
Jul-20-18Initiated SunTrust Buy $14
Jun-28-18Initiated Raymond James Outperform
Jun-01-18Reiterated Laidlaw Buy $10 → $15
May-31-18Reiterated Maxim Group Buy $8 → $14
Mar-26-18Resumed H.C. Wainwright Buy $11
Nov-28-17Reiterated Maxim Group Buy $5 → $8
Nov-21-17Initiated ROTH Capital Buy
Nov-10-17Resumed H.C. Wainwright Buy $7
Jul-17-17Reiterated H.C. Wainwright Buy $5 → $7
Aug-11-16Reiterated Laidlaw Buy $20 → $10
Mar-24-20 04:23PM  Biotech stocks have held up better than the broader market and these five are potential winners MarketWatch +6.67%
Mar-23-20 08:32AM  Viking Therapeutics (NASDAQ:VKTX) Is In A Good Position To Deliver On Growth Plans Simply Wall St. -6.25%
Feb-28-20 08:35AM  VKTX: Podium Presentation at EASL Zacks Small Cap Research
07:28AM  The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO Benzinga
Feb-27-20 05:45AM  Edited Transcript of VKTX earnings conference call or presentation 26-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Feb-26-20 04:15PM  Viking Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update PR Newswire
Feb-24-20 07:30AM  Viking Therapeutics to Participate in Upcoming Investor Conferences PR Newswire
Feb-19-20 07:30AM  Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2019 on February 26, 2020 PR Newswire
Feb-05-20 04:11PM  13 Key NASH Drug Candidates To Watch For In A Potential $30-Billion Market Benzinga
Jan-06-20 07:30AM  Viking Therapeutics to Present at Biotech Showcase 2020 PR Newswire
Dec-14-19 09:44PM  Is Viking Therapeutics, Inc. (VKTX) A Good Stock To Buy? Insider Monkey
Dec-06-19 08:00AM  12 Biotech Stocks Primed For A Short Squeeze Benzinga +5.54%
Nov-21-19 06:50AM  VKTX: Phase2b Trial of VK2809 Underway Zacks Small Cap Research
Nov-19-19 07:05AM  Viking Therapeutics Announces Initiation of Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH) PR Newswire -7.45%
Nov-15-19 12:27AM  Edited Transcript of VKTX earnings conference call or presentation 5-Nov-19 1:30pm GMT Thomson Reuters StreetEvents
Nov-12-19 07:30AM  Viking Therapeutics to Participate in Upcoming Investor Conferences PR Newswire +5.84%
Nov-09-19 03:53PM  Were Hedge Funds Right About Souring On Viking Therapeutics, Inc. (VKTX)? Insider Monkey
Nov-06-19 08:30AM  VKTX: VK2809 IND Filed; P2b Trial to Initiate in 4Q19 Zacks Small Cap Research -6.01%
Nov-05-19 05:09PM  US Indexes Close Mostly Higher Tuesday GuruFocus.com +19.21%
07:00AM  Viking Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update PR Newswire
Oct-31-19 07:30AM  Viking Therapeutics to Report Financial Results for Third Quarter 2019 on November 5, 2019 PR Newswire
Sep-25-19 07:30AM  Viking Therapeutics to Present at 2019 Cantor Global Healthcare Conference PR Newswire
Sep-23-19 02:37PM  We Think Viking Therapeutics (NASDAQ:VKTX) Can Easily Afford To Drive Business Growth Simply Wall St.
Sep-09-19 10:00AM  Better Buy: Intercept Pharmaceuticals vs. Viking Therapeutics Motley Fool
Aug-28-19 07:30AM  Viking Therapeutics to Participate in Upcoming Investor Conferences PR Newswire
Aug-13-19 07:00AM  3 Top Small-Cap Stocks to Buy in August Motley Fool
Aug-11-19 09:15AM  Is Viking Therapeutics a Buy? Motley Fool
Aug-08-19 01:31AM  Edited Transcript of VKTX earnings conference call or presentation 1-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-06-19 01:02AM  Viking Therapeutics Inc (VKTX) Q2 2019 Earnings Call Transcript Motley Fool
Aug-05-19 04:42PM  Where Will Viking Therapeutics Be in 1 Year? Motley Fool
Aug-02-19 11:30AM  VKTX: Awaiting Feedback from FDA regarding pre-IND submission; Phase 2b trial in NASH expected to initiate 2H19 Zacks Small Cap Research
Aug-01-19 04:05PM  Viking Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update PR Newswire
Jul-31-19 02:06PM  Options Traders Load Up On VKTX Calls Ahead of Earnings Schaeffer's Investment Research
Jul-25-19 04:05PM  Viking Therapeutics to Report Financial Results for Second Quarter 2019 on August 1, 2019 PR Newswire
Jul-02-19 04:05PM  Viking Therapeutics Appoints Kathy Rouan, Ph.D., to Board of Directors PR Newswire
Jun-20-19 02:15PM  Heres What Hedge Funds Think About Viking Therapeutics, Inc. (VKTX) Insider Monkey
May-31-19 02:22PM  3 Stocks to Buy and Hold for the Next 50 Years Motley Fool
May-28-19 07:30AM  Viking Therapeutics to Participate in Upcoming Investor Conferences PR Newswire -8.20%
May-17-19 06:00AM  3 Small-Cap Biotech Stocks You Can Buy Right Now Motley Fool
May-14-19 11:06AM  Have Insiders Been Buying Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares? Simply Wall St. +5.27%
May-09-19 11:06AM  Were Hedge Funds Right About Dumping Viking Therapeutics, Inc. (VKTX) ? Insider Monkey
May-08-19 12:03AM  Edited Transcript of VKTX earnings conference call or presentation 2-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-07-19 06:00AM  3 Top Biotech Stocks to Buy in May Motley Fool -6.51%
May-03-19 03:00PM  VKTX: Pre-IND Meeting with FDA in Summer 2019; Phase 2b NASH Trial to Initiate 2H19 Zacks Small Cap Research
May-02-19 09:10PM  Viking Therapeutics Inc (VKTX) Q1 2019 Earnings Call Transcript Motley Fool
04:05PM  Viking Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update PR Newswire
Apr-30-19 07:30AM  Viking Therapeutics to Participate in Upcoming Investor Conferences PR Newswire
Apr-27-19 08:16AM  2 Reasons Gilead Sciences' NASH Program Could Bounce Back Motley Fool
Apr-25-19 07:30AM  Viking Therapeutics to Report Financial Results for First Quarter 2019 on May 2, 2019 PR Newswire
Apr-12-19 09:45AM  VKTX: VK2809 5 mg Data Presented at EASL Zacks Small Cap Research -6.22%
Apr-11-19 08:52AM  Viking Therapeutics Jumps as New Liver Drug Gets Positive Results Bloomberg
07:02AM  Viking Therapeutics Presents New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The International Liver Congress 2019 PR Newswire
Apr-08-19 05:00PM  Why Viking Therapeutics Stock Perked Up in March Motley Fool
Apr-06-19 08:03AM  Here's Why Investors Are Betting Against These 2 Biotech Stocks Motley Fool
Apr-04-19 07:30AM  Viking Therapeutics to Present New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The International Liver Congress 2019 PR Newswire
Mar-31-19 09:00AM  3 Top Value Stocks to Buy Right Now Motley Fool
Mar-29-19 04:31PM  Here's What Pushed Viking Therapeutics Higher on Friday Motley Fool +16.80%
10:57AM  The Best Approach to Trading Lyft TheStreet.com
Mar-28-19 07:30AM  Viking Therapeutics to Participate in Upcoming Investor Conferences PR Newswire
Mar-22-19 11:39AM  Harry Boxer: 3 biotech stocks with momentum MarketWatch -10.99%
Mar-19-19 01:56AM  Edited Transcript of VKTX earnings conference call or presentation 13-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
Mar-14-19 04:20PM  VKTX: Phase 2b Trial for VK2809 to Initiate 2H19 Zacks Small Cap Research -6.42%
02:31AM  Viking Therapeutics (VKTX) Q4 2018 Earnings Conference Call Transcript Motley Fool
Mar-13-19 04:05PM  Viking Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update PR Newswire
01:15PM  Shareholders Are Raving About How The Viking Therapeutics (NASDAQ:VKTX) Share Price Increased 346% Simply Wall St.
Mar-12-19 06:00AM  3 Stocks That Could Double Your Money Motley Fool
Mar-06-19 07:30AM  Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2018 on March 13, 2019 PR Newswire
Feb-27-19 01:25PM  Is Viking Therapeutics a Buy? Motley Fool
Feb-26-19 07:30AM  Viking Therapeutics to Participate in Upcoming Investor Conferences and Events PR Newswire
Feb-25-19 07:40AM  Research Report Identifies Wolverine World Wide, Viking Therapeutics, Ampio Pharmaceuticals, ArcelorMittal, Delphi Technologies, and Unit with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-21-19 08:00AM  Healthcare Companies Investors are Watching ACCESSWIRE
Feb-19-19 09:35AM  4 Healthcare Stocks Looking to Start Strong on Tuesday (2/19/19) ACCESSWIRE
Feb-17-19 08:20AM  3 Top Biotech Stocks to Buy in February Motley Fool
Feb-14-19 10:08AM  Should You Buy Viking Therapeutics After Gilead Drug Failure? InvestorPlace
Feb-12-19 04:20PM  Gilead's (GILD) Late-Stage Study on Liver Disease Drug Fails Zacks +10.60%
02:57PM  Here's Why Viking Therapeutics Rose as Much as 13.9% Today Motley Fool
02:25PM  These Healthcare Stocks Could Surpass Investor Expectations ACCESSWIRE
11:01AM  Viking Therapeutics Breaks Out After Gilead's Clinical Failure Investopedia
Feb-07-19 09:57PM  Ligand Pharmaceuticals Inc (LGND) Q4 2018 Earnings Conference Call Transcript Motley Fool
Jan-23-19 03:10PM  VKTX: No Cardio Toxicity Concerns for VK2809 Zacks Small Cap Research
Jan-17-19 01:40PM  Viking Therapeutics Stock Regains Ground Investopedia
06:55AM  Citron Says Ligand Has 80% Downside in Explosive Note Investopedia
Jan-16-19 04:18PM  Ligand Crashes To Nearly 2-Year Low After Short-Seller Bashes It Investor's Business Daily -6.10%
03:35PM  Ligand Pharmaceuticals Hit By Bearish Citron Report Benzinga
Jan-13-19 09:00AM  3 Great Stocks Under $10 Motley Fool
Jan-12-19 06:00PM  3 Top Biotech Stocks to Buy in January Motley Fool
Jan-11-19 06:11PM  NASH Space in Focus in 2019 as Firms Look to Diversify Zacks
08:59AM  Here's Why Viking Therapeutics Slid 32.2% in December Motley Fool
Jan-08-19 05:13PM  Here's Why Viking Therapeutics Skyrocketed 88.4% in 2018 Motley Fool
Jan-04-19 08:00AM  Biotech Stocks Set to Start 2019 Off with a Bang ACCESSWIRE +8.84%
Jan-02-19 07:30AM  Viking Therapeutics to Present at Biotech Showcase 2019 PR Newswire +8.76%
Dec-28-18 07:05PM  3 Top Small-Cap Stocks to Buy Right Now Motley Fool
Dec-27-18 03:54PM  Why Viking Therapeutics Sank Today Motley Fool -8.75%
Dec-26-18 10:32AM  3 Biotech Stocks That Are Too Cheap to Ignore Motley Fool +11.73%
08:18AM  Better Buy: Intercept Pharmaceuticals vs. Viking Therapeutics Motley Fool
Dec-21-18 12:50PM  Could Viking Therapeutics, Inc.s (NASDAQ:VKTX) Investor Composition Influence The Stock Price? Simply Wall St. -6.19%
Dec-18-18 02:38PM  Edited Transcript of VKTX earnings conference call or presentation 7-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Dec-12-18 01:40AM  Hedge Funds Are Betting On Viking Therapeutics, Inc. (VKTX) Insider Monkey
Dec-10-18 10:28AM  Why Viking Therapeutics Stock Continued to Slide in November Motley Fool
Dec-08-18 03:03PM  Here's Why Madrigal Pharmaceuticals Fell 39.4% in November Motley Fool
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta, which is in Phase 2b clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis. The company's lead drug candidate also includes VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery. It is also developing VK0612, an orally available Phase 2b-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta for X-linked adrenoleukodystrophy. Viking Therapeutics, Inc. was founded in 2012 and is headquartered in San Diego, California.